Allurion Technologies Inc. (ALUR)
NYSE: ALUR · IEX Real-Time Price · USD
1.260
+0.140 (12.50%)
At close: Jul 2, 2024, 4:00 PM
1.240
-0.020 (-1.59%)
After-hours: Jul 2, 2024, 7:48 PM EDT
Allurion Technologies Revenue
Allurion Technologies had revenue of $48.78M in the twelve months ending March 31, 2024, down -25.60% year-over-year. Revenue in the quarter ending March 31, 2024 was $9.39M, a -33.30% decrease year-over-year. In the year 2023, Allurion Technologies had annual revenue of $53.47M, a decrease of -16.73%.
Revenue (ttm)
$48.78M
Revenue Growth
-25.60%
P/S Ratio
1.24
Revenue / Employee
$97,367
Employees
501
Market Cap
60.44M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 53.47M | -10.74M | -16.73% |
Dec 31, 2022 | 64.21M | 25.97M | 67.91% |
Dec 31, 2021 | 38.24M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionALUR News
- 4 days ago - Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement - Business Wire
- 6 days ago - Allurion Announces Launch of Offering of Common Stock and Warrants - Business Wire
- 12 days ago - Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss - Business Wire
- 21 days ago - Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery - Business Wire
- 27 days ago - Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer - Business Wire
- 4 weeks ago - Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s - Business Wire
- 4 weeks ago - Allurion to Participate in Two Upcoming Investor Conferences in June 2024 - Business Wire
- 6 weeks ago - Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss - Business Wire